Intrinsic Value of S&P & Nasdaq Contact Us

Vallon Pharmaceuticals, Inc. VLON NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Intrinsic Value
N/A
Negative cash flow

Vallon Pharmaceuticals, Inc. (VLON) has 17 known insider and institutional holders on record. The largest holder is Arcturus Therapeutics Holdings Inc. with 843,750 shares. Other notable holders include Hertz Walter Marc and Agro Albert.

VLON Insider Ownership

Top Holder
Arcturus Therapeutics Holdings Inc.
843,750 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Arcturus Therapeutics Holdings Inc. 10 Percent Owner 843,750 2021-02-10
100%
2 Hertz Walter Marc 10 Percent Owner, Officer: Chief Executive Officer 385,510 2023-04-24
46%
3 Agro Albert Chief Medical Officer 172,189 2023-04-24
20%
4 Chaturvedi Vipin Chief Scientific Officer 172,189 2023-04-24
20%
5 Kelly Leanne Chief Financial Officer 83,333 2023-09-26
10%
6 Kelly Leanne M. Chief Financial Officer 50,000 2022-03-01
6%
7 Salmon Pharma Gmbh 10 Percent Owner 47,063 2021-02-12
6%
8 Szekeres David Leslie Director 34,483 2023-08-14
4%
9 Baker David Charles Director 34,483 2023-08-14
4%
10 Rongen Roelof Director 34,483 2023-08-14
4%
11 Simpson Camilla V Director 34,483 2023-08-14
4%
12 Toren Penny SVP, Regul Affairs & Prog Mgmt 25,000 2021-05-18
3%
13 Levi Ofir Director 15,000 2021-05-18
2%
14 Chhabra Meenu Director 15,000 2022-03-09
2%
15 Thorell Marella Director 9,506 2022-12-15
1%
16 Ammer Richard Director 7,500 2022-06-10
1%
17 Payne Joseph E Director 7,500 2022-06-10
1%

No ownership data available for VLON.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message